Former UCSF scientist and founder of Jikoro Sciences, Michael is a scientist who is interested in the interface of biotechnology and synthetic biology. The Amadi lab at ASDRP works on projects related to genomics, metabolomics, and biotechnology/bioengineering. Michael, a serial entrepreneur, is interested in the interface of biomaterials, tech, and synthetic biology. The Amadi lab at ASDRP works on protein engineering, drug discovery, biotechnology, material engineering, and artificial intelligence projects.

Clinton has a Masters in Bioinformatics (University of Guelph) and a Masters of Science in Cellular and Molecular Medicine (University of Ottawa). He also has an Honors Bachelor's degree in Biological Sciences (Carnegie Mellon University). His main areas of focus include Bioinformatics, Data Analysis, Python programming, Biology, Science, Cancer Research and ESL. Professionally, Clinton is a qualified Bioinformatician/Biologist/Instructor and knows how to deal with different types of biological data to derive meaningful relationships using Python, SAS, R and Unix.

Experienced computational cognitive neuroscientist proficient in Computational Neuroscience, Neuroimaging, Behavioral Sciences, Neuroinformatics, Artificial Intelligence (AI), Data Science, Machine Learning (ML), Design Thinking, and Bioinformatics. Brining extensive experience in designing, gathering, and analyzing cutting-edge neuroimaging data studies using various modalities such as fMRI, NIRS, EEG, and simultaneous EEG-fMRI. Additionally, she is expertised in incorporating Large Language Models (LLMs) into cognitive science research.

Dr. Madhulika Jupelli received her PhD in cellular immunology from the University of Texas, San Antonio, and did her post-doctoral training at Cedars Sinai Medical Center and at the Los Angeles Children’s Hospital in infectious diseases. Following this, Dr. Jupelli’s industry career led her to several medium- and large- biopharmaceutical companies, including her work at Bristol Myers Squibb, and more recently at Pfizer. Dr. Jupelli has to her name three FDA clinical trials, including a Phase III clinical trial for GBT021601 (Osivelotor) for the treatment of Sickle cell disease. 

Martin received his MSc in Medical Genetics and Genomics at University of Glasgow in Scotland and  his BSc in Human Biology at UC San Diego. His research interests focus on studying genetic and epigenetic regulation of biological mechanisms and interactions to better understand their effects on genomic expression and modifications. I have previously studied viral genetics and mutational analysis of viral genomes and proteins.

Dr. Poudyal is a resident of San Leandro, CA. He started his high school education in Agriculture from India, B.Sc Agriculture from Nepal, M.Sc in Seed Technology from Scotland and finally he received a Pd.D from China in Agronomy research on Plant Tissue Culture/Biotechnology. He is interested to do mentoring on plant tissue culture, work on urban farming as well as vegetables and their role on health. "Working from LAB (to generating technology and making discoveries), to LAND (to implement said technology and knowledge), and eventually to LAP (to enjoy and benefit all creatures through innovation)"

Gayathri is an experienced medicinal biochemist interested in pushing forwards the frontiers of molecular medicine. She received her M.Pharm in Pharmaceutical Analysis from Anna University and has several years of experience as a lecturer, and in quality control and in inorganic/analytical biochemistry. The Renganathan research group applies small molecule phytochemistry in a robust drug discovery platform towards understanding the molecular mechanisms of human disease. Additionally, the group uses a variety of biophysical computational tools to understand the interaction of small molecules with their protein targets.The Renganathan research group works on the interface of chemistry and biology, using both experimental and computational techniques to find phytochemicals with clinical potential.

Vasudha Salgotra is a research professional with a background in analytical chemistry and pharmacy. She has years of experience in supporting preclinical activities in drug development and delivery for small and large biologics. Her professional journey includes designing and validating plate-based immunoassays (ELISAs) and other bioanalytical techniques.

Soumya’s expertise as an environmental scientist ranges from using environmental DNA (eDNA) and genomics for understanding ecological systems and the impact of human activities and forest fires on Northern California forest ecology. Ms. Suresh's Environmental Science groups deal with conservation issues with plants and wildlife. Our groups employs various scientific collection and analysis methods such as molecular biology, field data collection, lab specimen growth and care, and permit application. Soumya received her Master's in Natural Resources from Oregon State University.

Dr. John Wang received his PhD in Molecular and Cell Biology from Indiana University, and following that was a postdoctoral reserach fellow at Stanford Medical School in Oncology. Following this, Dr. Wang has been a leader in modern cancer immunotherapy, and has served as the chief scientific officer of a leading biotech company. Dr. Wang and his colleagues have previously placed multiple candidates, including most recently an interleukin-15 construct, into human clinical trials with the FDA.

Dr. Zhang holds a PhD in Biomedical Sciences from Hong Kong and has also completed two post-doctoral fellowships, one at MD Anderson Medical School (University of Texas) and the University of Connecticut. She has coauthored over twenty peer-reviewed publications in cancer biology and oncology, and is a 10+ year expert in molecular oncology.